Quantitative Methods and Modeling (29of35) Complex Generics – Sep. 25-26, 2019

Liang Zhao from the Division of Quantitative Methods and Modeling in the Office of Generic Drugs discusses modeling and simulation for new and generics drugs. He also provides case introductions and discusses about current utilities of Quantitative Clinical Pharmacology (QCP) and Physiologically-based Pharmacokinetic (PBPK) models.

Learn more at https://www.fda.gov/drugs/cder-small-...


_______________________________
FDA CDER’s Small Business and Industry Assistance (SBIA) educates and provides assistance in understanding the regulatory aspects of human drug products & clinical research.

Visit https://www.fda.gov/cdersbia and https://www.fda.gov/cdersbialearn for news and a repository of training activities.

Email: [email protected]
Phone: (301) 796-6707 I (866) 405-5367
LinkedIn:   / cder-small-business-and-industry-assistance  
Twitter:   / fda_drug_info  
CDER small business e-mail update subscription: https://updates.fda.gov/subscriptionm...